Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis

Abstract

Aberrantly hypermethylated genes in human lung cancers were searched for by a genome scanning technique, methylation-sensitive-representational difference analysis (MS-RDA). A total of 59 DNA fragments were isolated as those methylated more heavily in either/both of two lung squamous cell carcinoma cell lines, EBC-1 and LK-2, than in a primary culture of normal human bronchial epithelium, NHBE. Thirty-four DNA fragments, whose hypermethylation was confirmed in primary squamous cell carcinomas, were sequenced. By database searches, 17 of them were shown to be located within 2 kb of putative CpG islands, and five of the 17 DNA fragments had transcribed regions of known genes in their vicinities. By RT–PCR of the five genes in the carcinoma cell lines and NHBE, decreased expression of HTR1B (5-hydroxytryptamine receptor 1B) and EDN1 (endothelin-1) was observed. Sequencing after bisulfite modification showed that the CpG island in the promoter region of HTR1B was hypermethylated, while that of EDN1 was not. Demethylation and re-expression of HTR1B were observed after treatment of LK-2 cells with 5-aza-2′-deoxycytidine. In primary lung cancers, decreased mRNA expression of HTR1B was observed in 11 of 20 cases, and that of EDN1 was in 16 of 20 cases. Immunohistochemical analysis of endothelin-1 confirmed that its immunoreactivity was reduced in squamous cell carcinoma cells compared with that in normal bronchial epithelial cells. Considering that endothelin-1 induces apoptosis in melanoma cells and that silencing of endothelin receptor B is observed in prostate cancers, its reduced expression was speculated to confer a growth advantage to lung cancer cells. MS-RDA was shown to isolate DNA fragments that are hypermethylated and silenced, such as HTR1B, and those whose expressions are altered and the methylation statuses outside the promoter region are altered, such as EDN1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Al Moustafa AE, Yansouni C, Alaoui-Jamali MA, O'Connor-McCourt M . 1999 Clin. Cancer Res. 5: 681–686

  • Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1998 Adv. Cancer Res. 72: 141–196

  • Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO . 1994 J. Biol. Chem. 269: 17228–17237

  • Demchyshyn L, Sunahara RK, Miller K, Teitler M, Hoffman BJ, Kennedy JL, Seeman P, Van Tol HH, Niznik HB . 1992 Proc. Natl. Acad. Sci. USA 89: 5522–5526

  • Eguchi K, Kanai Y, Kobayashi K, Hirohashi S . 1997 Cancer Res. 57: 4913–4915

  • Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS . 1990 J. Exp. Med. 172: 1741–1748

  • Gardiner-Garden M, Frommer M . 1987 J. Mol. Biol. 196: 261–282

  • Harris CC, Reddel R, Pfeifer A, Iman D, McMenamin M, Trump BF, Weston A . 1991 IARC Sci. Publ. 105: 294–304

  • Henke W, Herdel K, Jung K, Schnorr D, Loening SA . 1997 Nucleic Acids Res. 25: 3957–3958

  • Jakowlew SB, Mariano JM, You L, Mathias A . 1997 Biochim. Biophys. Acta. 1353: 157–170

  • Jones PA, Laird PW . 1999 Nat. Genet. 21: 163–167

  • Kadokami Y, Lewis RV . 1995 Anal. Biochem. 226: 193–195

  • Kelsey G, Bodle D, Miller HJ, Beechey CV, Coombes C, Peters J, Williamson CM . 1999 Genomics 62: 129–138

  • Larsen F, Gundersen G, Lopez R, Prydz H . 1992 Genomics 13: 1095–1107

  • Markewitz BA, Kohan DE, Michael JR . 1995 Am. J. Physiol. 268: L192–L200

  • Masaki T, Yanagisawa M, Goto K . 1992 Med. Res. Rev. 12: 391–421

  • Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A . 1990 Am. J. Respir. Cell. Mol Biol. 3: 145–151

  • McDowell DG, Burns NA, Parkes HC . 1998 Nucleic Acids Res. 26: 3340–3347

  • Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . 1995 Nat. Met. 1: 686–692

  • Moghal N, Neel BG . 1998 Mol. Cell. Biol. 18: 6666–6678

  • Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW . 1996 Cancer Res. 56: 663–668

  • Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS . 1997 Cancer Res. 57: 35–37

  • Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG . 1999 Proc. Natl. Acad. Sci. USA 96: 12754–12759

  • Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T . 1998 J. Biol. Chem. 273: 12584–12592

  • Rein T, Zorbas H, DePamphilis ML . 1997 Mol. Cell. Biol. 17: 416–426

  • Sambrook J, Russel DW . 2000 Molecular Cloning, 3rd edn Cold Spring Harbor Laboratory Press, New York

  • Sekido Y, Fong KM, Minna JD . 1998 Biochim. Biophys. Acta. 1378: F21–F59

  • Sengupta PK, Smith BD . 1998 Biochim. Biophys. Acta. 1443: 75–89

  • Sugimura T, Ushijima T . 2000 Mutat. Res. 462: 235–246

  • Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T, Nagao M . 1997 Proc. Natl. Acad. Sci. USA 94: 2284–2289

  • Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T . 1988 Nature 332: 411–415

Download references

Acknowledgements

The authors are grateful to Drs T Niki and T Yamada for providing tumor samples and preparing paraffin block sections; to Dr M Nagao for supportive discussions; and to Drs T Kuramoto and K Asada for critical reading of the manuscript. D Takai is a recipient of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research. This study was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare; by a Grant-in-Aid for Human Genome and Gene Therapy; by a Grant-in-Aid from the Ministry of Education, Science, Culture and Sports; and by a grant from the Hishinomi Foundation for Cancer Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshikazu Ushijima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takai, D., Yagi, Y., Wakazono, K. et al. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 20, 7505–7513 (2001). https://doi.org/10.1038/sj.onc.1204940

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204940

Keywords

This article is cited by

Search

Quick links